Shorts

1:09
What are Some of the Misconceptions Your Colleagues Might Have About the use of CAR-T in Neurology?
7 months ago
by
Amanda L Piquet, MD(+1 more)

1:07
What We Still Don’t Know About Hormone Therapy in Alzheimer Disease
7 months ago
by
Louie Pasculli

0:45
Implications of Positive Phase 3 METEROID Study of Satralizumab in MOGAD
7 months ago
by
Michael Levy, MD, PhD

0:55
Why Medical Students Should Consider Neurology
7 months ago
by
Michael Rosenbloom, MD, FAAN(+1 more)

0:45
AAN 2026: Function and Use of Newly Approved Cala kIQ Plus Device
7 months ago
by
Kate Hornbluth, PhD

0:45
AAN 2026: Clinical Pearls for Identifying and Treating CNS Vasculitis
7 months ago
by
Edith Graham, MD

0:31
What Advice Would you Give to Neurologists Starting Their Careers?
7 months ago
by
Jorge G. Ortiz Garcia , MD, MSCR, FAAN(+1 more)

0:19
AAN 2026: Call to Action on Epilepsy for the Wider Neurology Community
7 months ago
by
Anup Patel, MD

1:05
AAN 2026: Key Facts About Huntington Disease Neurologists Should Know
7 months ago
by
Victor Sung, MD

0:31
What is the Biggest Piece of Misinformation in Neurology Right Now?
7 months ago
by
Jonathan E. Howard, MD(+1 more)

1:05
AAN 2026: Notable Advances and Overused Buzzwords
7 months ago
by
Johan Luthman, PhD

1:05
2026 AAN Annual Meeting: Trends to Watch
7 months ago
by
Paul George, MD, PhD, FAAN(+1 more)

1:12
Key Focus Areas of the 2026 AAN Meeting
7 months ago
by
Paul George, MD, PhD, FAAN(+1 more)

1:28
Emerging Concepts on the Horizon for Neurointerventional Surgery
7 months ago
by
Marco Meglio(+1 more)

1:28
Functionality of Zeto One EEG Headset for Seizure Detection
7 months ago
by
Marco Meglio(+1 more)

1:28
Clinical Considerations to Optimize Neurointerventional Surgery
7 months ago
by
Marco Meglio(+1 more)

1:26
Emerging Targeted Therapies for Myasthenia Gravis
7 months ago
by
Isabella Ciccone, MPH(+1 more)

1:33
Design Considerations for Stem-Cell Based MS Trials
7 months ago
by
Jeffrey Cohen, MD(+1 more)

1:06
Phase 3 Updates for MASCOT Trial of MSA Agent Amlenetug
7 months ago
by
Marco Meglio(+1 more)

0:44
Why Pediatric Stroke Collaboration Matters
7 months ago
by
Beth Cavanaugh, MD(+1 more)

1:06
Understanding Mechanism of Investigational Lu AF28996 in Parkinson Disease
7 months ago
by
Marco Meglio(+1 more)

1:18
Recapping the 2026 ACTRIMS Forum
7 months ago
by
Isabella Ciccone, MPH(+1 more)

1:06
FDA Approval of High-Dose Nusinersen for Spinal Muscular Atrophy
7 months ago
by
Marco Meglio(+1 more)

1:25
Living a Full Life with MS: Finding Hope and Specialized Care
7 months ago
by
Constance V. Katsafanas, DO(+1 more)

1:07
Treating RLS Without Drug Interactions
8 months ago
by
Louie Pasculli(+1 more)

0:45
MS Roundtable: Educational Changes Needed With New Diagnostic Criteria
8 months ago
by
Marco Meglio(+1 more)

1:17
MS Roundtable: Treating Multiple Sclerosis Before Symptoms Arise
8 months ago
by
Marco Meglio(+1 more)

1:17
MS Roundtable: Top Takeaways From 2024 McDonald Criteria
8 months ago
by
Marco Meglio(+1 more)

1:17
Purple Day: Exciting, Novel Treatments on the Horizon for Epilepsy
8 months ago
by
Marco Meglio(+1 more)

0:35
Overviewing Phase 3 DAWN Efficacy Data of Daratumumab in NMOSD
8 months ago
by
Michael Levy, MD, PhD(+1 more)
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Phase 3 NIMBLE Trial: Cemdisiran Efficacy and Safety Results in gMG
2
Myelin Repair Research in MS: Lessons From Clinical Trials and the Road Ahead
3
From Glucose to Cognition: Where Repurposed Diabetes Drugs Stand in Alzheimer Disease
4
FDA Requires NAION Warning Across GLP-1 Receptor Agonist Class
5
